Enanta Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.72 |
Market Cap |
$1.67 B |
Shares Outstanding |
19.67 M |
Public Float |
14.62 M |
Address |
500 Arsenal Street Watertown Massachusetts 02472 United States |
Employees | - |
Website | http://www.enanta.com |
Updated | 07/08/2019 |
Enanta Pharmaceuticals, Inc. engages in the research and development of small molecule drugs for the treatment of viral infections and liver diseases. It offers the two protease inhibitors Maviret and the Viekira Pak for the treatment of chronic hepatitis C virus. The company was founded by Peter O. |